Impact Biomedical Achieves COVID-19 Success with Equivir and 3F Biofragrance
Jun 24, 2020 14:00 HKT |  |
|
New EIU report shows lack of integrated follow up care can increase risk of subsequent heart attack or stroke in APAC economies
Jun 24, 2020 04:30 HKT |  |
|
Hua Medicine Successfully Completes SEED (HMM0301), Dorzagliatin Phase III Monotherapy Trial
Jun 18, 2020 18:30 HKT |  |
|
Novotech Partners with South Korea's Pusan National University Hospital
Jun 18, 2020 11:00 HKT |  |
|
Impact Biomedical Announces Publication of COVID-19 Research in Peer-Reviewed Journal
Jun 17, 2020 18:00 HKT | |
|
VerifyMe and Gohar Group's Techind Form Strategic Relationship to Address Product Authentication and Brand Protection in India's Large and Emerging Pharmaceutical Market
Jun 15, 2020 21:00 HKT |  |
|
Agilex Biolabs Encourages Biotechs to Move Delayed Trials to Australia at BIO Digital 2020
Jun 11, 2020 05:00 HKT |  |
|
SinoMab Announces Clinical Results on its First-in-target SM03 at EULAR 2020 Congress
Jun 10, 2020 07:52 HKT |  |
|
TrialTrove Data Shows Australia is Open for Business says Avance Clinical at BIO Digital 2020
Jun 09, 2020 20:00 HKT |  |
|
Joonghun Pharmaceutical of Korea Targets Overseas Markets for Coronavirus Diagnostic Kits
Jun 09, 2020 11:00 HKT |  |
|
Blockchain Holdings Ltd. subsidiary TraceSafe and Toronto Wolfpack Sign Contract for Wearable Technology to Safely Reopen Lamport Stadium
Jun 02, 2020 00:00 HKT |  |
|
Impact Biomedical and GRDG Sciences Announce Medical Technology Package Valued at USD 1.39 Billion (SGD 1.97 Billion) by Independent Experts
Jun 01, 2020 13:00 HKT | |
|
After Scientific Breakthrough: Digid Seeks FDA Approval for Its Rapid Corona Antigen Test
May 30, 2020 10:00 HKT |  |
|
Sino Biopharmaceutical Announces 2020 First Quarterly Results
May 28, 2020 19:59 HKT |  |
|
Nature Publishes Preclinical Characterization and Primate Efficacy Data on Junshi Biosciences' COVID-19 Neutralizing Antibodies
May 27, 2020 10:41 HKT | |
|
Novotech and Endpoints to present APAC Clinical Trial webinar series
May 26, 2020 19:00 HKT | |
|
New Drug Application of Penpulimab Co-developed by Sino Biopharmaceutical and Akeso Accepted by the National Medical Products Administration
May 26, 2020 17:16 HKT | |
|
Strong Effectiveness of NanoViricides Drug Candidates Observed in an Animal Model of Infection by an ACE2-using Human Coronavirus
May 20, 2020 18:15 HKT |  |
|
Agilex Biolabs Presents the Australian Advantage, including the World's Largest Rebate on Clinical Trial Spend, at BIO Korea 2020
May 20, 2020 16:00 HKT | |
|
Results from Clinical Trials of Penpulimab in Combination with Anlotinib for 1L HCC Co-developed by Sino Biopharmaceutical and Akeso Accepted for Presentation at ASCO Annual Meeting
May 19, 2020 17:50 HKT | |
|